Bio Techne Earnings Estimate

TECH Stock  USD 64.63  0.62  0.95%   
The next projected EPS of Bio Techne is estimated to be 0.49245 with future projections ranging from a low of 0.475 to a high of 0.51. Bio Techne's most recent 12-month trailing earnings per share (EPS TTM) is at 0.49. Please be aware that the consensus of earnings estimates for Bio Techne Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Bio Techne is projected to generate 0.49245 in earnings per share on the 30th of June 2026. Bio Techne earnings estimates show analyst consensus about projected Bio Techne Corp EPS (Earning Per Share). It derives the highest and the lowest estimates based on Bio Techne's historical volatility. Many public companies, such as Bio Techne, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Bio Techne Revenue Breakdown by Earning Segment

By analyzing Bio Techne's earnings estimates, investors can diagnose different trends across Bio Techne's analyst sentiment over time as well as compare current estimates against different timeframes. The Bio Techne's current Gross Profit is estimated to increase to about 954.3 M, while Pretax Profit Margin is projected to decrease to 0.07. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Bio Techne Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private.

Bio Techne Earnings Estimation Breakdown

The calculation of Bio Techne's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Bio Techne is estimated to be 0.49245 with the future projection ranging from a low of 0.475 to a high of 0.51. Please be aware that this consensus of annual earnings estimates for Bio Techne Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.0
0.47
Lowest
Expected EPS
0.49245
0.51
Highest

Bio Techne Earnings Projection Consensus

Suppose the current estimates of Bio Techne's value are higher than the current market price of the Bio Techne stock. In this case, investors may conclude that Bio Techne is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Bio Techne's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 30th of June 2026Current EPS (TTM)
1586.58%
0.0
0.49245
0.49

Bio Techne Earnings History

Earnings estimate consensus by Bio Techne Corp analysts from Wall Street is used by the market to judge Bio Techne's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we suggest analyzing not only Bio Techne's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Bio Techne Quarterly Gross Profit

190.19 Million

As of now, Bio Techne's Retained Earnings are increasing as compared to previous years. The Bio Techne's current Price Earnings Ratio is estimated to increase to 104.34, while Retained Earnings Total Equity is projected to decrease to under 812.3 M. The Bio Techne's current Net Income Applicable To Common Shares is estimated to increase to about 344.5 M, while Common Stock Shares Outstanding is projected to decrease to under 169.4 M.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Techne's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
62.5864.6766.76
Details
Intrinsic
Valuation
LowRealHigh
58.1767.2169.30
Details
Naive
Forecast
LowNextHigh
55.6757.7659.85
Details
15 Analysts
Consensus
LowTargetHigh
63.7070.0077.70
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of Bio assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Bio Techne. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Bio Techne's stock price in the short term.

Bio Techne Earnings per Share Projection vs Actual

Actual Earning per Share of Bio Techne refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Bio Techne Corp predict the company's earnings will be in the future. The higher the earnings per share of Bio Techne, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Bio Techne Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Bio Techne, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Bio Techne should always be considered in relation to other companies to make a more educated investment decision.

Bio Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Bio Techne's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
null
nullnullnullnull
null
nullnullnullnull
2025-11-05
2025-09-300.430.42-0.01
2025-08-06
2025-06-300.50.530.03
2025-05-07
2025-03-310.510.560.05
2025-02-05
2024-12-310.390.420.03
2024-10-30
2024-09-300.380.420.0410 
2024-08-07
2024-06-300.490.490.0
2024-05-01
2024-03-310.450.480.03
2024-02-01
2023-12-310.410.4-0.01
2023-10-31
2023-09-300.440.41-0.03
2023-08-08
2023-06-300.550.550.0
2023-05-03
2023-03-310.530.530.0
2023-02-02
2022-12-310.620.47-0.1524 
2022-11-01
2022-09-300.590.45-0.1423 
2022-08-04
2022-06-300.520.51-0.01
2022-05-04
2022-03-310.50.540.04
2022-02-01
2021-12-310.450.470.02
2021-11-02
2021-09-300.430.460.03
2021-08-05
2021-06-300.430.470.04
2021-05-06
2021-03-310.390.450.0615 
2021-02-02
2020-12-310.340.410.0720 
2020-11-05
2020-09-300.270.360.0933 
2020-08-04
2020-06-300.190.250.0631 
2020-04-30
2020-03-310.290.350.0620 
2020-02-04
2019-12-310.280.27-0.01
2019-10-29
2019-09-300.260.270.01
2019-08-06
2019-06-300.330.31-0.02
2019-04-30
2019-03-310.290.30.01
2019-02-05
2018-12-310.250.270.02
2018-10-30
2018-09-300.240.250.01
2018-08-07
2018-06-300.320.340.02
2018-05-02
2018-03-310.290.30.01
2018-02-06
2017-12-310.230.260.0313 
2017-10-31
2017-09-300.220.230.01
2017-08-08
2017-06-300.250.270.02
2017-05-02
2017-03-310.230.240.01
2017-02-07
2016-12-310.210.2-0.01
2016-10-31
2016-09-300.20.210.01
2016-08-17
2016-06-300.240.23-0.01
2016-05-03
2016-03-310.220.250.0313 
2016-02-02
2015-12-310.210.220.01
2015-10-28
2015-09-300.210.2-0.01
2015-08-06
2015-06-300.220.220.0
2015-05-05
2015-03-310.230.22-0.01
2015-02-03
2014-12-310.210.210.0
2014-10-28
2014-09-300.220.21-0.01
2014-08-11
2014-06-300.210.220.01
2014-04-28
2014-03-310.220.240.02
2014-02-04
2013-12-310.20.19-0.01
2013-10-29
2013-09-300.20.210.01
2013-08-06
2013-06-300.210.210.0
2013-04-30
2013-03-310.220.220.0
2013-02-05
2012-12-310.190.190.0
2012-10-23
2012-09-300.20.19-0.01
2012-07-31
2012-06-300.210.2-0.01
2012-05-01
2012-03-310.220.230.01
2012-01-31
2011-12-310.20.19-0.01
2011-10-25
2011-09-300.210.2-0.01
2011-08-02
2011-06-300.190.210.0210 
2011-05-03
2011-03-310.20.210.01
2011-02-01
2010-12-310.170.170.0
2010-10-26
2010-09-300.180.180.0
2010-08-03
2010-06-300.180.17-0.01
2010-05-04
2010-03-310.20.19-0.01
2010-02-02
2009-12-310.170.170.0
2009-10-28
2009-09-300.180.180.0
2009-08-04
2009-06-300.170.170.0
2009-04-28
2009-03-310.180.190.01
2009-02-03
2008-12-310.160.160.0
2008-10-22
2008-09-300.160.190.0318 
2008-08-05
2008-06-300.170.180.01
2008-04-29
2008-03-310.170.190.0211 
2008-01-29
2007-12-310.140.150.01
2007-10-24
2007-09-300.140.140.0
2007-08-07
2007-06-300.140.140.0
2007-05-01
2007-03-310.150.150.0
2007-01-30
2006-12-310.120.120.0
2006-10-25
2006-09-300.120.130.01
2006-08-08
2006-06-300.120.120.0
2006-04-25
2006-03-310.120.130.01
2006-01-31
2005-12-310.10.110.0110 
2005-10-27
2005-09-300.10.110.0110 
2005-08-16
2005-06-300.110.120.01
2005-04-26
2005-03-310.110.110.0
2005-02-01
2004-12-310.090.090.0
2004-10-21
2004-09-300.090.090.0
2004-08-10
2004-06-300.090.08-0.0111 
2004-04-27
2004-03-310.080.090.0112 
2004-01-27
2003-12-310.070.080.0114 
2003-10-23
2003-09-300.070.080.0114 
2003-08-12
2003-06-300.070.080.0114 
2003-05-01
2003-03-310.070.080.0114 
2003-01-28
2002-12-310.060.060.0
2002-10-25
2002-09-300.060.060.0
2002-08-13
2002-06-300.060.070.0116 
2002-04-23
2002-03-310.060.060.0
2002-01-29
2001-12-310.050.050.0
2001-10-18
2001-09-300.050.050.0
2001-08-14
2001-06-300.050.060.0120 
2001-05-01
2001-03-310.050.050.0
2001-01-30
2000-12-310.040.040.0
2000-10-24
2000-09-300.040.040.0
2000-08-15
2000-06-300.040.050.0125 
2000-04-25
2000-03-310.030.050.0266 
2000-02-08
1999-12-310.030.030.0
1999-10-21
1999-09-300.030.030.0
1999-08-10
1999-06-300.030.030.0
1999-04-26
1999-03-310.030.030.0
1999-02-02
1998-12-310.080.090.0112 
1998-10-22
1998-09-300.070.090.0228 
1998-08-11
1998-06-300.110.130.0218 
1998-04-28
1998-03-310.090.10.0111 
1998-02-03
1997-12-310.080.080.0
1997-10-23
1997-09-300.080.080.0
1997-08-12
1997-06-300.080.090.0112 
1997-04-22
1997-03-310.070.080.0114 
1997-01-28
1996-12-310.060.060.0
1996-10-24
1996-09-300.060.060.0
1996-08-15
1996-06-300.070.070.0
1996-04-22
1996-03-310.060.070.0116 

About Bio Techne Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Bio Techne earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Bio Techne estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Bio Techne fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings1.2 B1.3 B
Retained Earnings Total Equity1.5 B812.3 M
Earnings Yield 0.01  0.01 
Price Earnings Ratio 99.37  104.34 
Price Earnings To Growth Ratio(2.26)(2.15)

Currently Active Assets on Macroaxis

When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Bio Techne Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is there potential for Life Sciences Tools & Services market expansion? Will Bio introduce new products? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.143
Dividend Share
0.32
Earnings Share
0.49
Revenue Per Share
7.762
Quarterly Revenue Growth
(0.01)
Understanding Bio Techne Corp requires distinguishing between market price and book value, where the latter reflects Bio's accounting equity. The concept of intrinsic value - what Bio Techne's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Bio Techne's price substantially above or below its fundamental value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Bio Techne's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.